The 2017 Queen's Speech took place today [21 June] at the State Opening of Parliament. With the Government having announced that there will be no Queen's Speech in 2018, this Queen's Speech sets out the Government's legislative agenda for the next two years.
The UK pharmaceutical industry trade body, the Association of the British Pharmaceutical Industry (ABPI), have responded to the Prime Minister's speech on the Government's negotiating objectives for exiting the EU.
Alison Culpan, ABPI’s Scotland Director, covers last week’s announcement of the Scottish Government’s programme for government and reflects on what its focus on science and innovation means for the pharmaceutical industry.
The Conservative Party launched their 2017 General Election manifesto on Thursday 18 May in Halifax. ‘Forward, Together’ is the Conservatives' vision for the UK under the leadership of Theresa May.
The new Health Service Medical Supplies Bill has completed its path through Parliament and is now law. David Watson, ABPI Director of Pricing & PPRS, analyses the key aspects of the new legislation, the areas where ABPI had concerns, the immediate relevance to industry and where we will continue...
The Labour Party launched their 2017 General Election Manifesto on Tuesday 16 May in Bradford. 'For The Many, Not The Few' is the Party's vision for a Labour Government under the leadership of Jeremy Corbyn.
The Liberal Democrats launched their 2017 General Election Manifesto on Wednesday 17 May in London. ‘Change Britain’s Future’ is the Lib Dems vision of “leading the opposition” under Tim Farron.
The Scottish National Party launched their 2017 General Election manifesto on Tuesday 30 May in Perth. ‘Stronger For Scotland’ is the SNP's vision for the next Westminster government.
Over the last year the Government has been making a number of positive moves around the future of medicines manufacturing in the UK. Following the General Election and the Queen’s Speech, it is an appropriate time to reflect on where we stand now.
As the dust settles after a surprising outcome to the 2015 General Election, the focus will now shift towards David Cameron’s new government- its ministers, priorities and policies – and for us, what this will mean for the pharmaceutical industry in the UK.